Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 42 (RPL23AP42)

Target
RPL23AP42
Molecular classification
Pseudogene, Other
01

Overview

Ribosomal protein L23a pseudogene 42 (RPL23AP42) is a processed pseudogene located on chromosome 3q26.1[2][6]. It is one of many pseudogenes related to the ribosomal protein L23a (RPL23A), which encodes a component of the 60S ribosomal subunit involved in ribosome structure and protein synthesis[1][5][7]. Unlike the functional RPL23A gene, RPL23AP42 is classified as a pseudogene and is not expected to produce a functional protein product[2][6]. Pseudogenes such as RPL23AP42 typically arise from duplication or retrotransposition events and generally lack biological function, though some ribosomal protein pseudogenes have been implicated as non-coding RNAs with regulatory potential[3][4]. There is currently no evidence that RPL23AP42 itself is expressed, has a biological function, or is involved in disease, and it is not considered a therapeutic target[2][3][6]. The gene is not linked to any specific safety concerns, biomarker roles, or drug interactions.

Other names
RPL23A_13_431hCG16001RPL23AP42
02

Biological functions

Other (pseudogene, no known protein product or function)
03

Disease associations

Other (no established disease role for this specific pseudogene)

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 42 (RPL23AP42).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 42 (RPL23AP42).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call